6.15 USD
▲+0.36+0.65%
2026-08-03
市值
$685.66M
市盈率
—
EPS
-0.08
股息率
—
52 周区间
5.44 – 9.42
成交量
63.21K
Beta
4.78
目标价
18.67
52W 低 5.4452W 高 9.42
价格走势
公司简介
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated l...